nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Four-Year Pathology Review of the Near Total Face Transplant
|
Bergfeld, W. |
|
|
13 |
10 |
p. 2750-2764 |
artikel |
2 |
Algorithm for Total Face and Multiorgan Procurement From a Brain-Dead Donor
|
Brazio, P.S. |
|
|
13 |
10 |
p. 2743-2749 |
artikel |
3 |
Angiotensin II Type 1 Receptor Antibodies: Great Expectations?
|
Tinckam, K. |
|
|
13 |
10 |
p. 2515-2516 |
artikel |
4 |
Biological Implications of Extracellular Adenosine in Hepatic Ischemia and Reperfusion Injury
|
Zimmerman, M.A. |
|
|
13 |
10 |
p. 2524-2529 |
artikel |
5 |
Correction of Diabetes Mellitus by Transplanting Minimal Mass of Syngeneic Islets Into Vascularized Small Intestinal Segment
|
Kakabadze, Z. |
|
|
13 |
10 |
p. 2550-2557 |
artikel |
6 |
Dialysis-Associated Steal Syndrome
|
Cyrus, N. |
|
|
13 |
10 |
p. 2768-2770 |
artikel |
7 |
Donor Age and Early Graft Failure After Lung Transplantation: A Cohort Study
|
Baldwin, M.R. |
|
|
13 |
10 |
p. 2685-2695 |
artikel |
8 |
Donor Cancer Transmission in Kidney Transplantation: A Systematic Review
|
Xiao, D. |
|
|
13 |
10 |
p. 2645-2652 |
artikel |
9 |
Eosinophils Are Not Required for the Induction and Maintenance of an Alloantibody Response
|
Cravedi, P. |
|
|
13 |
10 |
p. 2696-2702 |
artikel |
10 |
Eosinophil-Targeted Therapy: Not the Panacea for Antibody-Mediated Rejection?
|
Kers, J. |
|
|
13 |
10 |
p. 2522-2523 |
artikel |
11 |
Epidemiology and Molecular Characterization of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae in Transplant Recipients
|
Clancy, C.J. |
|
|
13 |
10 |
p. 2619-2633 |
artikel |
12 |
Erratum
|
|
|
|
13 |
10 |
p. 2779 |
artikel |
13 |
Fatal Cardiac and Renal Allograft Rejection With Lenalidomide Therapy for Light-Chain Amyloidosis
|
Meyers, D.E. |
|
|
13 |
10 |
p. 2730-2733 |
artikel |
14 |
Higher Risk of Kidney Graft Failure in the Presence of Anti-Angiotensin II Type-1 Receptor Antibodies
|
Taniguchi, M. |
|
|
13 |
10 |
p. 2577-2589 |
artikel |
15 |
Hypogammaglobulinemia: Time to Reevaluate?
|
Avery, R.K. |
|
|
13 |
10 |
p. 2517-2518 |
artikel |
16 |
Immune Cell-Derived C3a and C5a Costimulate Human T Cell Alloimmunity
|
Cravedi, P. |
|
|
13 |
10 |
p. 2530-2539 |
artikel |
17 |
Increased T Cell Glucose Uptake Reflects Acute Rejection in Lung Grafts
|
Chen, D.L. |
|
|
13 |
10 |
p. 2540-2549 |
artikel |
18 |
Induction of Cardiac Allograft Tolerance Across a Full MHC Barrier in Miniature Swine by Donor Kidney Cotransplantation
|
Madariaga, M.L. |
|
|
13 |
10 |
p. 2558-2566 |
artikel |
19 |
Literature Watch Implications for transplantation
|
Kreisel, Daniel |
|
|
13 |
10 |
p. 2513 |
artikel |
20 |
Metabolic Assessment Prior to Total Pancreatectomy and Islet Autotransplant: Utility, Limitations and Potential
|
Lundberg, R. |
|
|
13 |
10 |
p. 2664-2671 |
artikel |
21 |
Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury
|
Hricik, D.E. |
|
|
13 |
10 |
p. 2634-2644 |
artikel |
22 |
Native Portal Vein Embolization for Persistent Hyperoxaluria Following Kidney and Auxiliary Partial Liver Transplantation
|
Elias, N. |
|
|
13 |
10 |
p. 2739-2742 |
artikel |
23 |
Optimizing Recovery, Utilization and Transplantation Outcomes for Kidneys From Small, ≤20 kg, Pediatric Donors
|
Maluf, D.G. |
|
|
13 |
10 |
p. 2703-2712 |
artikel |
24 |
Persistent Hyperparathyroidism Is a Major Risk Factor for Fractures in the Five Years After Kidney Transplantation
|
Perrin, P. |
|
|
13 |
10 |
p. 2653-2663 |
artikel |
25 |
Pilot Study Exploring Lung Allograft Surfactant Protein A (SP-A) Expression in Association With Lung Transplant Outcome
|
D’Ovidio, F. |
|
|
13 |
10 |
p. 2722-2729 |
artikel |
26 |
Polyreactive Antibodies Developing Amidst Humoral Rejection of Human Kidney Grafts Bind Apoptotic Cells and Activate Complement
|
Porcheray, F. |
|
|
13 |
10 |
p. 2590-2600 |
artikel |
27 |
Pretransplant Sensitization Against Angiotensin II Type 1 Receptor Is a Risk Factor for Acute Rejection and Graft Loss
|
Giral, M. |
|
|
13 |
10 |
p. 2567-2576 |
artikel |
28 |
Preventive Intervention for Living Donor Psychosocial Outcomes: Feasibility and Efficacy in a Randomized Controlled Trial
|
Dew, M.A. |
|
|
13 |
10 |
p. 2672-2684 |
artikel |
29 |
Reducing Infection Transmission in Solid Organ Transplantation Through Donor Nucleic Acid Testing: A Cost-Effectiveness Analysis
|
Lai, J.C. |
|
|
13 |
10 |
p. 2611-2618 |
artikel |
30 |
Reversibility of Acquired Amyloid Polyneuropathy After Liver Retransplantation
|
Antonini, T.M. |
|
|
13 |
10 |
p. 2734-2738 |
artikel |
31 |
Stent Placement for Treating IVC Stenosis Following “Left at Right” Adult Liver Transplantation
|
Mizuno, S. |
|
|
13 |
10 |
p. 2775-2776 |
artikel |
32 |
Successful Treatment of Chronic HCV Infection Should Not Preclude Kidney Donation to an HCV Negative Recipient
|
Cruzado, J.M. |
|
|
13 |
10 |
p. 2773-2774 |
artikel |
33 |
The AJT Report
|
Pondrom, Sue |
|
|
13 |
10 |
p. 2511-2512 |
artikel |
34 |
The Concerns of “Left at Right” Adult Liver Transplantation
|
Chan, K.-M. |
|
|
13 |
10 |
p. 2777-2778 |
artikel |
35 |
Updated Recommendations for Use of VariZIG—United States, 2013
|
|
|
|
13 |
10 |
p. 2765-2767 |
artikel |
36 |
Urinary Biomarkers and Kidney Transplant Rejection: Fine-Tuning the Radar
|
Srinivas, T.R. |
|
|
13 |
10 |
p. 2519-2521 |
artikel |
37 |
What Is the Impact of Hypogammaglobulinemia on the Rate of Infections and Survival in Solid Organ Transplantation? A Meta-Analysis
|
Florescu, D.F. |
|
|
13 |
10 |
p. 2601-2610 |
artikel |
38 |
Written Informed Consent for Living Kidney Donors: Practices and Compliance With CMS and OPTN Requirements
|
Thiessen, C. |
|
|
13 |
10 |
p. 2713-2721 |
artikel |
39 |
5 Years After Tragedy: An Update on Organ Procurement Travel in Michigan
|
Sheetz, K.H. |
|
|
13 |
10 |
p. 2771-2772 |
artikel |